Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke-Reference-Cited by-同舟云学术

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke

Published:2013-09 Issue:9 Volume:4 Page:e790-e790
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Yang-Wei Fann D,Lee S-Y,Manzanero S,Tang S-C,Gelderblom M,Chunduri P,Bernreuther C,Glatzel M,Cheng Y-L,Thundyil J,Widiapradja A,Lok K-Z,Foo S L,Wang Y-C,Li Y-I,Drummond G R,Basta M,Magnus T,Jo D-G,Mattson M P,Sobey C G,Arumugam T V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2013326.pdf

Reference53 articles.

1. Hou ST, MacManus JP . Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol 2002; 221: 93–148.

2. Broughton BR, Reutens DC, Sobey CG . Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40: e331–e339.

3. Sims NR, Muyderman H . Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010; 1802: 80–91.

4. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849–1857.

5. Iadecola C, Anrather J . Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 2011; 14: 1363–1368.

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesoporous manganese-doped nano-antioxidant suppresses pyroptosis for effective ischemic stroke therapy;Chemical Engineering Journal;2024-10

2. MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions;Archiv der Pharmazie;2024-08-23

3. HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome;Journal of Neuroimmunology;2024-08

4. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain–Barré syndrome: two case reports and review of the literature;Frontiers in Immunology;2024-07-23

5. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders;Future Journal of Pharmaceutical Sciences;2024-07-09